Testing effectiveness (Phase 2)Study completedNCT01831466What this trial is testingTofacitinib Ointment For Chronic Plaque PsoriasisWho this might be right forPsoriasis VulgarisPsoriasis Pfizer 476
Testing effectiveness (Phase 2)Study completedNCT00539695What this trial is testingLow Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHDWho this might be right forAcute Lymphoblastic LeukemiaALLAcute Myelogenous Leukemia+7 more Baylor College of Medicine 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07178457What this trial is testingBrentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant MaintenanceWho this might be right forCutaneous T Cell Lymphoma (CTCL)Brentuximab Vedotin Assistance Publique - Hôpitaux de Paris 84
Not applicableActive Not RecruitingNCT02718001What this trial is testingEdwards EVOQUE Eos MISCEND StudyWho this might be right forMitral Valve Regurgitation (Degenerative or Functional) Edwards Lifesciences 123
Early research (Phase 1)UnknownNCT03823365What this trial is testingBlinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic LeukemiaWho this might be right forIndolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia A.O. Ospedale Papa Giovanni XXIII 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07702851What this trial is testingPolatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOPWho this might be right forDiffuse Large B-cell Lymphoma Yonsei University 47
Large-scale testing (Phase 3)Study completedNCT00641095What this trial is testingPhase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell LymphomaWho this might be right forLymphoma University College, London 370
Early research (Phase 1)UnknownNCT02968472What this trial is testingA Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell LeukemiaWho this might be right forB Acute Lymphoblastic Leukemia The First People's Hospital of Yunnan 30
Testing effectiveness (Phase 2)UnknownNCT02955628What this trial is testingRICE-ibrutinib in Relapsed DLBCLWho this might be right forDiffuse Large B Cell LymphomaDiffuse Large B-Cell Lymphoma Recurrent Singapore General Hospital 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT06425302What this trial is testingEvaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular LymphomaWho this might be right forLymphoma, Follicular Celgene 95
Early research (Phase 1)Looking for participantsNCT04892277What this trial is testingCD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell MalignanciesWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+5 more Mayo Clinic 25
Testing effectiveness (Phase 2)Study completedNCT00514475What this trial is testingZevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma Oslo University Hospital 160
Not applicableUnknownNCT05904522What this trial is testingHistopathological Changes in Mycosis FungoidesWho this might be right forMycosis Fungoides Bezmialem Vakif University 10
Early research (Phase 1)Study completedNCT00588328What this trial is testingThe Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment PlanningWho this might be right forLung CancerNon-Hodgkin's Lymphoma Memorial Sloan Kettering Cancer Center 35
Not applicableUnknownNCT00429065What this trial is testingTreatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.Who this might be right forNon-Hodgkin Lymphoma Instituto Nacional de Cancerologia de Mexico 30
Not applicableStudy completedNCT00097565What this trial is testingAn Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's LymphomaWho this might be right forLymphoma, Non Hodgkin Genentech, Inc. 2,740
Early research (Phase 1)Study completedNCT03305445What this trial is testingNivolumab/Ipilimumab-Primed Immunotransplant for DLBCLWho this might be right forRelapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma Icahn School of Medicine at Mount Sinai 6
Testing effectiveness (Phase 2)Study completedNCT00303953What this trial is testingPXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's LymphomaWho this might be right forRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell Lymphoma National Cancer Institute (NCI) 22
Not applicableStudy completedNCT00430053What this trial is testingClinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell LymphomaWho this might be right forLymphoma National Institutes of Health Clinical Center (CC) 100
Testing effectiveness (Phase 2)Ended earlyNCT02420795What this trial is testingAkt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forCentral Nervous System LymphomaGastric Mantle Cell LymphomaRecurrent Mantle Cell Lymphoma+4 more M.D. Anderson Cancer Center 16